Financial Performance - The company reported a basic earnings per share of 0.5700 yuan for 2024, an increase of 14% compared to 0.5000 yuan in 2023 [1] - The net profit for 2024 was 2.46 billion yuan, reflecting a 14.95% increase from 2.14 billion yuan in 2023 [1] - The return on equity (ROE) improved to 17.86% in 2024, up from 16.81% in 2023, marking a 6.25% increase [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 34,468.2 million shares, accounting for 79.2% of the circulating shares, with an increase of 334.93 million shares compared to the previous period [1] - The largest shareholder, Tibet Weixin Kang Enterprise Management Co., Ltd., holds 20,524.90 million shares, representing 47.17% of the total share capital [2] - New entrants among the top shareholders include Guangfa Medical Health Stock A and China Merchants Quantitative Selected Stock A, with holdings of 280.53 million shares and 258.70 million shares, respectively [2] Dividend Distribution - The company announced a dividend distribution plan of 1.8 yuan per share (including tax) [2]
卫信康:2024年报净利润2.46亿 同比增长14.95%